Zhi-Chao Wang (Zhichao Wang)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 15

Top Venues

The journal of pathology. Clinical research

Clinical and experimental dermatology

Cancer immunology, immunotherapy : CII

Disease markers

Shanghai 9th Peoples Hospital Affiliated to Shanghai Jiaotong University School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shanghai 9th Peoples Hospital Affiliated to Shanghai Jiaotong University School of Medicine Jul 01 2018

China

Surgical fellow of Plastic and Reconstructive Surgery :: Department of Plastic and Reconstructive Surgery

Zhongshan Hospital Fudan University Jul 01 2016 - Jun 30 2018

China

Surgical Resident :: Surgery

Publications

Yue-Hua Li, Man-Mei Long, Shun-Dong Dai, Zhi-Chao Wang
LARP4B gene mutation is involved in the development of neurofibroma. Clinical and experimental dermatology 48 (4) (2023)
Rehanguli Aimaier, Man-Hon Chung, Yihui Gu, Qingxiong Yu, Chengjiang Wei, Haibo Li, Zizhen Guo, Manmei Long, Yuehua Li, Wei Wang, Qingfeng Li, Zhi-Chao Wang
FOXM1 promotes neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor progression in a NUF2-dependent manner. Cancer gene therapy (2023)
Qiao-Ling Ruan, Zhi-Chao Wang, Cheng-Jiang Wei, Wei Wang, Qing-Luan Yang, Jing Wu, Yan-Min Wan, Ling-Ling Ge, Wen-Hong Zhang, Qing-Feng Li
Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1. Signal transduction and targeted therapy 8 (1) (2023)
Ling-Ling Ge, Zhi-Chao Wang, Cheng-Jiang Wei, Jing-Xuan Huang, Jun Liu, Yi-Hui Gu, Wei Wang, Qing-Feng Li
Unraveling intratumoral complexity in metastatic dermatofibrosarcoma protuberans through single-cell RNA sequencing analysis. Cancer immunology, immunotherapy : CII (2023)
Ming Li, Yongbo Liu, Chengxian Xu, Qun Zhao, Jianling Liu, Mingyan Xing, Xiaoming Li, Haiwei Zhang, Xiaoxia Wu, Lingxia Wang, Yangjing Ou, Xuanhui Wu, Xiaoming Zhao, Han Liu, Lin Qiu, Fang Li, Jinbao Li, Wuwei Rong, Yan Luo, Jiangshan Deng, Xiuzhe Wang, Zhi-Chao Wang, Yuwu Zhao, Ankang Lv, Qingfeng Li, Haibing Zhang
Ubiquitin-binding domain in ABIN1 is critical for regulating cell death and inflammation during development. Cell death and differentiation 29 (10) (2022)
Yuehua Li, Chengjiang Wei, Wei Wang, Qingfeng Li, Zhi-Chao Wang
Tropomyosin receptor kinase B (TrkB) signalling: targeted therapy in neurogenic tumours. The journal of pathology. Clinical research 9 (2) (2022)
Yuehua Li, Chengjiang Wei, Wei Wang, Qingfeng Li, Zhi-Chao Wang
Tropomyosin receptor kinase B (TrkB) signalling: targeted therapy in neurogenic tumours. The journal of pathology. Clinical research 9 (2) (2022)
Yuehua Li, Chengjiang Wei, Wei Wang, Qingfeng Li, Zhi-Chao Wang
Tropomyosin receptor kinase B (TrkB) signalling: targeted therapy in neurogenic tumours. The journal of pathology. Clinical research (2022)
Yuehua Li, Chengjiang Wei, Wei Wang, Qingfeng Li, Zhi-Chao Wang
Tropomyosin receptor kinase B (TrkB) signalling: targeted therapy in neurogenic tumours. The journal of pathology. Clinical research 9 (2) (2022)
Yuehua Li, Chengjiang Wei, Wei Wang, Qingfeng Li, Zhi-Chao Wang
Tropomyosin receptor kinase B (TrkB) signalling: targeted therapy in neurogenic tumours. The journal of pathology. Clinical research 9 (2) (2022)
Dun Wang, Lingling Ge, Zizhen Guo, Yuehua Li, Beiyao Zhu, Wei Wang, Chengjiang Wei, Qing-Feng Li, Zhi-Chao Wang
Efficacy and Safety of Trametinib in Neurofibromatosis Type 1-Associated Plexiform Neurofibroma and Low-Grade Glioma: A Systematic Review and Meta-Analysis. Pharmaceuticals (Basel, Switzerland) 15 (8) (2022)
Yue-Hua Li, Man-Mei Long, Shun-Dong Dai, Zhi-Chao Wang
LARP4B gene mutation is involved in the development of neurofibroma. Clinical and experimental dermatology (2022)
Qingxiong Yu, Hainan Zhu, Huijing Wang, Rehanguli Aimaier, Manhon Chung, Zhi-Chao Wang, Qing-Feng Li
M6A-Related Bioinformatics Analysis Reveals a New Prognostic Risk Signature in Cutaneous Malignant Melanoma. Disease markers 2022 (2022)
Yi-Hui Gu, Xi-Wei Cui, Jie-Yi Ren, Man-Mei Long, Wei Wang, Cheng-Jiang Wei, Rehanguli Aimaier, Yue-Hua Li, Man-Hon Chung, Bin Gu, Qing-Feng Li, Zhi-Chao Wang
Selection of internal references for RT-qPCR assays in Neurofibromatosis type 1 (NF1) related Schwann cell lines. PloS one 16 (2) (2021)
Cheng-Jiang Wei, Shu-Chen Gu, Jie-Yi Ren, Yi-Hui Gu, Xiang-Wen Xu, Xin Chou, Xiang Lian, Xin Huang, Hai-Zhou Li, Ya-Shan Gao, Bin Gu, Tao Zan, Zhi-Chao Wang, Qing-Feng Li
The impact of host immune cells on the development of neurofibromatosis type 1: The abnormal immune system provides an immune microenvironment for tumorigenesis. Neuro-oncology advances 1 (1) (2019)

Zhi-Chao Wang.css-eqlu8i{font-size:small;padding-left:4px;} (Zhichao Wang)

Publication Activity (10 Years)

Top Topics

Top Venues

Zhi-Chao Wang (Zhichao Wang)